Simplicity Panel HPV 14-Target

Single-tube HPV detection assay that identifies 14 high-risk HPV genotypes, satisfying cervical cytology screening requirements with streamlined testing methodology.

Multi-marker panel assay for HPV-related cervical disease detection. Includes E7 and E6 antibody-based detection methods for comprehensive HPV screening. Designed for pathological assessment of cervical tissue samples.

Real-time PCR-based assays designed to simultaneously detect multiple pathogens across respiratory, gastrointestinal, sexually transmitted infection, and HPV categories. These multiplex panels enable comprehensive pathogen identification in a single test for improved diagnostic efficiency.

A fully enclosed diagnostic kit with preloaded reagents for 6-plex detection of HPV types (HPV16, HPV18, and others) using cervical exfoliated cells and genital secretion samples. The kit employs magnetic beads extraction, purification, and qPCR method with results available within 2 hours and internal control monitoring throughout the process. It requires no freezer storage or transportation.

This diagnostic kit uses real-time multiple fluorescent PCR technology combined with an Automated Fully Enclosed qPCR Instrument. It is used for in vitro qualitative detection of high-risk HPV16, HPV18, and 16 other high-risk types (HPV26, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV53, HPV56, HPV58, HPV68, HPV59, HPV66, HPV73, and HPV82) in cervical exfoliated cells or reproductive tract secretions. Test results assist in HPV auxiliary diagnosis.

Molecular diagnostic test for human papillomavirus detection using polymerase chain reaction technology. Enables nucleic acid-based identification of HPV pathogens for clinical screening applications.

Multiplex real-time PCR kit for simultaneous detection and genotyping of 28 HPV types. Enables comprehensive cervical cancer screening and risk stratification through E6/E7 mRNA analysis. Delivers rapid, multiplexed results for clinical HPV surveillance and patient management.

PCR-based human papillomavirus detection assay capable of identifying 23 HPV genotypes including 18 high-risk and 5 low-risk variants for cervical cancer screening and auxiliary diagnosis.

Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.

A nucleic acid detection kit designed to identify 14 types of high-risk human papillomavirus (HPV) with specific genotyping for HPV types 16 and 18. This test kit enables comprehensive HPV screening and risk stratification for cervical cancer prevention. The kit provides detailed genotyping information for clinical management and patient counseling.

Molecular diagnostic test for detection and genotyping of human papillomavirus. Supports cervical cancer screening and HPV-related disease diagnosis.

The Allplex HPV28 Assay is a real-time PCR-based diagnostic test that simultaneously detects 28 human papillomavirus (HPV) types for cervical cancer screening and risk stratification. This high-multiplex assay integrates seamlessly into automated laboratory workflows, enabling rapid syndromic detection with comprehensive HPV genotyping in a single reaction.